Novel Imaging for Genitourinary Cancers

Host: Jay D. Raman, MD, FACS

Co-Host: Marc Bjurlin, DO

CME Available: https://auau.auanet.org/node/37333

At the conclusion of this activity, participants will be able to

1. Review clinical trials and available PET imaging agents for the detection of prostate, kidney and urothelial cancer.

2. Assess the indications, risks, and benefits of incorporating PET imaging to guide treatment of urologic cancer.

ACKNOWLEDGEMENTS:

This series is supported by independent educational grants from:

Astellas

AstraZeneca

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Lantheus Medical Imaging

Merck & Co., Inc.

Pfizer, Inc.

Sanofi Genzyme